81 related articles for article (PubMed ID: 22740636)
1. The signal peptide of mouse mammary tumor virus-env: a phosphoprotein tumor modulator.
Feldman D; Roniger M; Bar-Sinai A; Braitbard O; Natan C; Love DC; Hanover JA; Hochman J
Mol Cancer Res; 2012 Aug; 10(8):1077-86. PubMed ID: 22740636
[TBL] [Abstract][Full Text] [Related]
2. Mouse mammary tumor virus Env-derived peptide associates with nucleolar targets in lymphoma, mammary carcinoma, and human breast cancer.
Bar-Sinai A; Bassa N; Fischette M; Gottesman MM; Love DC; Hanover JA; Hochman J
Cancer Res; 2005 Aug; 65(16):7223-30. PubMed ID: 16103073
[TBL] [Abstract][Full Text] [Related]
3. Nucleolar localization of mouse mammary tumor virus proteins in T-cell lymphomas.
Hoch-Marchaim H; Hasson T; Rorman E; Cohen S; Hochman J
Virology; 1998 Mar; 242(2):246-54. PubMed ID: 9514962
[TBL] [Abstract][Full Text] [Related]
4. The leader peptide of MMTV Env precursor localizes to the nucleoli in MMTV-derived T cell lymphomas and interacts with nucleolar protein B23.
Hoch-Marchaim H; Weiss AM; Bar-Sinai A; Fromer M; Adermann K; Hochman J
Virology; 2003 Aug; 313(1):22-32. PubMed ID: 12951018
[TBL] [Abstract][Full Text] [Related]
5. Life after Cleavage: The Story of a β-Retroviral (MMTV) Signal Peptide-From Murine Lymphoma to Human Breast Cancer.
Hochman J; Braitbard O
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366533
[TBL] [Abstract][Full Text] [Related]
6. A new immunization and treatment strategy for mouse mammary tumor virus (MMTV) associated cancers.
Braitbard O; Roniger M; Bar-Sinai A; Rajchman D; Gross T; Abramovitch H; La Ferla M; Franceschi S; Lessi F; Naccarato AG; Mazzanti CM; Bevilacqua G; Hochman J
Oncotarget; 2016 Apr; 7(16):21168-80. PubMed ID: 26934560
[TBL] [Abstract][Full Text] [Related]
7. Expression of mouse mammary tumor virus envelope protein does not prevent superinfection in vivo or in vitro.
Dzuris JL; Zhu W; Kapkov D; Golovkina TV; Ross SR
Virology; 1999 Oct; 263(2):418-26. PubMed ID: 10544114
[TBL] [Abstract][Full Text] [Related]
8. MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer.
Theodorou V; Kimm MA; Boer M; Wessels L; Theelen W; Jonkers J; Hilkens J
Nat Genet; 2007 Jun; 39(6):759-69. PubMed ID: 17468756
[TBL] [Abstract][Full Text] [Related]
9. MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways.
Callahan R; Smith GH
Oncogene; 2000 Feb; 19(8):992-1001. PubMed ID: 10713682
[TBL] [Abstract][Full Text] [Related]
10. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
11. Mouse mammary tumour virus-like env nucleotide and p14 signal peptide are present in feline mammary carcinomas, but not in neoplastic or dysplastic canine mammary lesions.
Civita P; Menicagli M; Scopelliti C; Lessi F; Millanta F; Borsacchi S; Parisi F; Freer G; Pistello M; Mazzanti CM; Poli A
PLoS One; 2018; 13(7):e0200839. PubMed ID: 30040851
[TBL] [Abstract][Full Text] [Related]
12. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.
White DE; Cardiff RD; Dedhar S; Muller WJ
Oncogene; 2001 Oct; 20(48):7064-72. PubMed ID: 11704830
[TBL] [Abstract][Full Text] [Related]
13. Mammary cancer stages in BALB/cV mice: mouse mammary tumor virus expression and virus-host interactions.
Slagle BL; Medina D; Butel JS
J Natl Cancer Inst; 1987 Aug; 79(2):323-35. PubMed ID: 3037152
[TBL] [Abstract][Full Text] [Related]
14. An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors.
Ross SR; Schmidt JW; Katz E; Cappelli L; Hultine S; Gimotty P; Monroe JG
J Virol; 2006 Sep; 80(18):9000-8. PubMed ID: 16940512
[TBL] [Abstract][Full Text] [Related]
15. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
[TBL] [Abstract][Full Text] [Related]
16. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of the tumor suppressing protein p53 is associated with the presence of mouse mammary tumor-like env gene sequences (MMTV-like) in human breast cancer.
Lawson JS; Tran DD; Ford C; Rawlinson WD
Breast Cancer Res Treat; 2004 Sep; 87(1):13-7. PubMed ID: 15377846
[TBL] [Abstract][Full Text] [Related]
18. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
19. Molecular events during B lymphocyte differentiation. Induction of endogenous mouse mammary tumor proviral envelope transcripts after B cell stimulation.
Sharma S; King LB; Corley RB
J Immunol; 1988 Oct; 141(7):2510-8. PubMed ID: 2844901
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations that contribute to breast cancer.
Callahan R
Biochem Soc Symp; 1998; 63():211-21. PubMed ID: 9513725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
